Vonoprazan versus proton pump inhibitors for the management of gastroesophageal reflux disease: A protocol for a systematic review with meta-analysis

BACKGROUND AND AIM: Vonoprazan, a novel potassium-competitive acid blocking agent, is used in the management of gastroesophageal reflux disease (GERD). We aim to perform a systematic review and meta-analysis for the comparison of the effects of vonoprazan and proton pump inhibitors (PPIs) in GERD in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hyun, Kim, Beom Jin, Choi, Geunjoo, Kim, Jae Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181618/
https://www.ncbi.nlm.nih.gov/pubmed/30278564
http://dx.doi.org/10.1097/MD.0000000000012574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181618/
https://www.ncbi.nlm.nih.gov/pubmed/30278564
http://dx.doi.org/10.1097/MD.0000000000012574

Ejemplares similares